Ibotta Inc. Class A Common Stock (IBTA)
StalwartFairStock Score: 15/100 — RISKY
Key Financials
| Current Price | $30.81 |
| Market Cap | $834M |
| P/E Ratio | -93.36 |
| ROE | -2.25% |
| Dividend Yield | —% |
| Sector | Technology |
Strengths
- Generates $44 million in annual free cash flow (5.3% yield on market cap)
- Conservative balance sheet with debt-to-equity of just 0.09, providing financial flexibility
Concerns
- Trades significantly above Graham Number ($6) with negative 530% margin of safety—limited downside protection
- Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
- Revenue declining at 10.0% year-over-year signals potential demand weakness or market share loss
- No meaningful dividend despite modest growth—total return depends entirely on multiple expansion
AI Analysis
Ibotta Inc. Class A Common Stock is a micro-cap technology company valued at $834 million. Revenue stands at $342 million, though the company is currently unprofitable. From a quality standpoint, Ibotta shows Altman Z-Score of 2.4 in the grey zone and modest 1% ROE. On valuation, the stock is commanding a steep 297.8x multiple, with trades far above its Graham Number ($6) with no margin of safety. Growth dynamics show revenue growing at -10.0% and profit growth of -101.3%. Our composite FairStock Score of 15/100 reflects below-average fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $44 million in annual free cash flow (5.3% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
At 298x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer